Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome

Affiliations

¹ Division of Therapeutic Immunology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden. Electronic address: olle.ringden@ki.se.

Comment

Olle Ringdén. Lancet Respir Med. 2015 Apr.

. 2015 Apr;3(4):e12.

doi: 10.1016/S2213-2600(15)00047-8.

¹ Division of Therapeutic Immunology, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden. Electronic address: olle.ringden@ki.se.

No abstract available

Comment in

Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome - authors' reply.
Wilson J, McKenna D, Liu KD, Matthay MA. Wilson J, et al. Lancet Respir Med. 2015 Apr;3(4):e12-3. doi: 10.1016/S2213-2600(15)00040-5. Lancet Respir Med. 2015. PMID: 25890655 No abstract available.

Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.
Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, Rogers AJ, Levitt J, Wiener-Kronish J, Bajwa EK, Leavitt A, McKenna D, Thompson BT, Matthay MA. Wilson JG, et al. Lancet Respir Med. 2015 Jan;3(1):24-32. doi: 10.1016/S2213-2600(14)70291-7. Epub 2014 Dec 17. Lancet Respir Med. 2015. PMID: 25529339 Free PMC article. Clinical Trial.